A Viveve Experience Normalizes Untreated Selective Serotonin Reuptake Inhibitor (SSRI) Sexuality Syndrome (VENUSSSS)

Michael Krychman, MD

Status: Unknown

Conditions: Sexual Dysfunction

Treatments: Device: Viveve System

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT03679702

VI-ISRP-034

Details and patient eligibility

About

A pilot study to investigate non-surgical treatment for women who suffer from sexual complaints secondary to SSRI Sexuality Syndrome.

Enrollment: 10 estimated patients

Sex: Female

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Currently using SSRI for 3 months at a stable dose

Exclusion criteria

• Pregnant, currently breastfeeding, or breast-fed within the last 6 months
• Has any implantable electrical device that could potentially be affected by use of radiofrequency.

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

10 participants in 1 patient group

Active treatment

Other group

Treatment:

Device: Viveve System